feed,title,long_url,short_url
ðŸ’°Barrons,"Sarepta Therapeutics Plunges on Drug Approval Doubts. Buy the Stock, Analysts Say.",https://barrons.com/articles/sarepta-therapeutics-stock-fda-8efe821b?mod=RTA,https://da.gd/gXB2PK
